Skip to main content
Caplight Logo









Evolved By Nature

Evolved By Nature

Private
Needham, MassachusettsHealthcare & Life Scienceshttps://evolvedbynature.com

Last Round

Series C

Jun 30, 2022

Total Funding Raised

$271M

Company Overview

Evolved By Nature operates in Healthcare & Life Sciences and is based in Needham, Massachusetts. Its latest recorded funding round was a Series C round in June 2022.

Evolved By Nature is a biotechnology company that develops sustainable, naturally derived bioactive peptides from silk protein for use in skincare, personal care, and textile applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Fashion & Beauty, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Evolved By Nature Comparables

Compare Evolved By Nature with similar companies based on industry and business-model similarity.

Evolved By Nature comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AMSilk
83%
Bolt Threads
82%
Cambrium
73%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Evolved By Nature Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CJun 30, 2022
Series BDec 24, 2021
StrategicJun 11, 2019
Early FundingOct 18, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Greg Altman

CEO

Executive Team

For institutional investors. Book with your work email.

Evolved By Nature Investors

Notable investors and investment history

Evolved By Nature investors
InvestorRounds
Emerald Development ManagersSeries C, Series B
Kraft Family FoundationSeries B, Series C
Mousse InvestmentsSeries C, Series B
Teachers' Venture GrowthSeries C
Mousse PartnersSeries C, Series B
Senator Investment GroupSeries C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors grew 100% MoM, reaching 3.8K.

  • Aug 19, 2025

    Launched two new skincare products in collaboration with Doré.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • launchesAug 20, 2026

    Evolved By Nature, Inc. announces FDA 510(k) clearance for New Day(TM) Skin Spray, a prescription topical emulsion spray for managing atopic dermatitis, as the product reaches patients through an initial launch in select markets from Massachusetts on Aug 20th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Evolved By Nature Filings

Explore SEC and related filing metadata, where available.

Evolved By Nature filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Evolved By Nature's valuation, stock price, and market status.

Is Evolved By Nature a public or private company?

Evolved By Nature is a private company.

What is the current stock price of Evolved By Nature?

Evolved By Nature is a private company, so its shares have no public market price. Caplight tracks Evolved By Nature's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Evolved By Nature worth (valuation)?

Valuation information for Evolved By Nature is not publicly available.

Can I buy Evolved By Nature stock?

Evolved By Nature shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Evolved By Nature's last funding round?

Evolved By Nature's most recent funding round was Series C on June 30, 2022.

Who are the main investors in Evolved By Nature?

Key investors in Evolved By Nature include Mousse Investments, Teachers' Venture Growth, Mousse Partners, Senator Investment Group.

Will Evolved By Nature IPO soon?

No public IPO plans have been announced for Evolved By Nature.

How can I track Evolved By Nature secondary market activity?

Caplight tracks bids, offers, and trades in Evolved By Nature's shares on secondary markets.

Firmographic Details

HeadquartersNeedham, Massachusetts
Employee Range59
Year Founded2013
Last FundingJun 30, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?